McKesson Gelecekteki Büyüme

Future kriter kontrolleri 2/6

McKesson kazanç ve gelirin sırasıyla yıllık 15% ve 8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 19% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 656.1% olacağı tahmin edilmektedir.

Anahtar bilgiler

15.0%

Kazanç büyüme oranı

19.0%

EPS büyüme oranı

Healthcare kazanç büyümesi20.8%
Gelir büyüme oranı8.0%
Gelecekteki özkaynak getirisi656.1%
Analist kapsamı

Good

Son güncelleme07 Nov 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff

Oct 09

McKesson: The Correction Is Not Over

Sep 10

McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

Aug 22
McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

McKesson Corporation: An Interesting Health Giant With A Hidden Gem

Jul 04

With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

May 09
With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

Mar 14
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

Feb 19

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Feb 16
McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

Jan 29
Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

McKesson: Why The Company Is Too Richly Valued

Jan 19

If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

Nov 20
If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Nov 08

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

Oct 30
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

McKesson: Still Trading For A Huge Discount

Sep 06

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Aug 21
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

Jul 27
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

Jun 28

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

May 23
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Apr 17
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

Feb 22
Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth

Feb 08

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

Feb 01

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

Jan 12
McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Dec 27

McKesson Corporation: Still Trading Below Intrinsic Value

Dec 13

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus

Oct 08

McKesson extends distribution partnership with CVS Health

Sep 29

Kazanç ve Gelir Büyüme Tahminleri

NYSE:MCK - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
3/31/2027417,1154,2955,6766,43011
3/31/2026389,6083,9524,8845,89115
3/31/2025359,5123,0975,0265,77210
9/30/2024330,1872,5364,3135,121N/A
6/30/2024313,7512,9593,2563,986N/A
3/31/2024308,9513,0023,6274,314N/A
12/31/2023301,5062,9982,8923,492N/A
9/30/2023291,0983,4874,3064,906N/A
6/30/2023284,0403,7554,4665,048N/A
3/31/2023276,7113,5634,6015,159N/A
12/31/2022273,9033,1464,1904,721N/A
9/30/2022272,0272,0613,9524,430N/A
6/30/2022268,4461,3964,6395,115N/A
3/31/2022263,9661,1193,8994,434N/A
12/31/2021257,0061,4154,3234,917N/A
9/30/2021250,991-4,8044,0984,753N/A
6/30/2021245,223-4,4943,2993,982N/A
3/31/2021238,228-4,5383,9014,542N/A
12/31/2020237,621-4,1895,2315,826N/A
9/30/2020234,1942,2283,9054,492N/A
6/30/2020231,0029222,8513,363N/A
3/31/2020231,0519063,8684,374N/A
12/31/2019224,945-9053,1253,615N/A
9/30/2019221,981-6263,0663,559N/A
6/30/2019217,4406014,5235,046N/A
3/31/2019214,319333,4794,036N/A
12/31/2018213,518-3192,5723,165N/A
9/30/2018210,9271132,7513,324N/A
6/30/2018209,913-384N/A2,543N/A
3/31/2018208,35762N/A4,345N/A
12/31/2017205,4424,805N/A2,756N/A
9/30/2017201,9554,539N/A3,155N/A
6/30/2017199,8514,846N/A3,626N/A
3/31/2017198,5335,194N/A4,744N/A
12/31/2016196,4982,051N/A6,415N/A
9/30/2016194,2672,044N/A5,349N/A
6/30/2016193,0712,359N/A5,077N/A
3/31/2016190,8842,290N/A3,672N/A
12/31/2015189,1312,237N/A2,449N/A
9/30/2015187,7162,090N/A4,198N/A
6/30/2015183,1151,950N/A3,384N/A
3/31/2015179,0451,775N/A3,112N/A
12/31/2014171,9521,780N/A3,893N/A
9/30/2014159,8041,462N/A2,488N/A
6/30/2014148,6291,402N/A2,602N/A
3/31/2014137,3921,419N/A3,136N/A
12/31/2013130,0761,278N/A2,679N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: MCK 'nin tahmini kazanç büyümesi (yıllık 15% ) tasarruf oranının ( 2.6% ) üzerindedir.

Kazançlar ve Piyasa: MCK şirketinin kazançlarının (yıllık 15% ) US pazarından (yıllık 15.4% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: MCK şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: MCK şirketinin gelirinin (yıllık 8% ) US pazarından (yıllık 8.9% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: MCK şirketinin gelirinin (yıllık 8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: MCK 'nin Özsermaye Getirisi'nin 3 yıl içinde çok yüksek olması tahmin ediliyor ( 656.1 %).


Büyüyen şirketleri keşfedin